Verstovsek Outlines Features of and Therapies for MPNs
In an article published by Targeted Oncology, Dr. Srdan Verstovsek, MD, Ph.D., discussed with a group of physicians the considerations he makes with the diagnosis and management of patients with myeloproliferative neoplasms (MPNs). Read Dr. Verstovsek's answers to questions such as, what are important diagnostic parameters of myelofibrosis, how do you treat patients with MDS/MPN, what is the best therapy, what risk assessment models are available for prognosis, and how does this affect the choice of therapy.